Renal dose norepinephrine!

Chest

Volumn 126, Issue 2, 2004, Pages 335-337

  Marik, Paul E ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; HYPERTENSIVE AGENT; NORADRENALIN; PROSTACYCLIN; PROSTAGLANDIN E2;

AUTOREGULATION; BLOOD PRESSURE; DOSE KIDNEY FUNCTION RELATION; EDITORIAL; HEAD INJURY; HUMAN; HYPOTENSION; HYPOVOLEMIA; ISCHEMIA; KIDNEY; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY FUNCTION; MEAN ARTERIAL PRESSURE; NONHUMAN; OLIGURIA; PRIORITY JOURNAL; RENOVASCULAR DISEASE; RESUSCITATION; SEPTIC SHOCK; SIDE EFFECT; VASCULAR DISEASE; VASOCONSTRICTION;

EID: 4143090468     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.126.2.335     Document Type: Editorial

References (25)

1. Lang EW, Lagopoulos J, Griffith J, et al. Cerebral vasomotor reactivity testing in head injury: the link between pressure and flow. J Neurol Neurosurg Psychiatry 2003; 74:1053-1059
2. Rordorf G, Koroshetz WJ, Ezzeddine MA, et al. A pilot study of drug-induced hypertension for treatment of acute stroke. Neurology 2001; 56:1210-1213
3. Marik PE, Varon J, Trask T. Management of head trauma. Chest 2002; 122:699-711
4. Kellum JA, Decker JM. Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 2001; 29:1526-1531
5. Marik PE. Low-dose dopamine: a systematic review. Intensive Care Med 2002; 28:877-883
6. Segal JM, Phang PT, Walley KR. Low-dose dopamine hastens onset of gut ischemia in a porcine model of hemorrhagic shock. J Appl Physiol 1992; 73:1159-1164
7. Marik PE, Mohedin M. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 1994; 272:1354-1357
8. Cronin RE, Erickson AM, de Torrente A, et al. Norepinephrine-induced acute renal failure: a reversible ischemic model of acute renal failure. Kidney Int 1978; 14:187-190
9. Cronin RE, de Torrente A, Miller PD, et al. Pathogenic mechanisms in early norepinephrine-induced acute renal failure: functional and histological correlates of protection. Kidney Int 1978; 14:115-125
10. Anderson WP, Korner PI, Selig SE. Mechanisms involved in the renal responses to intravenous and renal artery infusions of noradrenaline in conscious dogs. J Physiol 1981; 321:21-30
11. Llinas MT, Lopez R, Rodriguez F, et al. Role of COX-2-derived metabolites in regulation of the renal hemodynamic response to norepinephrine. Am J Physiol 2001; 281:F975-F982
12. Chatziantoniou C, Arendshorst WJ. Prostaglandin interactions with angiotensin, norepinephrine, and thromboxane in rat renal vasculature. Am J Physiol 1992; 262:F68-F76
13. Imig JD, Deichmann PC. Afferent arteriolar responses to ANG II involve activation of PLA2 and modulation by lipoxygenase and P-450 pathways. Am J Physiol 1997; 273: F274-F282
14. Pelayo JC. Renal adrenergic effector mechanisms: glomerular sites for prostaglandin interaction. Am J Physiol 1988; 254: F184-F190
15. Inscho EW, Carmines PK, Navar LG. Prostaglandin influences on afferent arteriolar responses to vasoconstrictor agonists. Am J Physiol 1990; 259:F157-F163
16. Desjars P, Pinaud M, Bugnon D, et al. Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med 1989; 17:426-429
17. Martin C, Papazian L, Perrin G, et al. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 1993; 103:1826-1831
18. Ledoux D, Astiz M, Carpati CM, et al. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 2000; 28:2729-2732
19. Di Giantomasso D, Morimatsu H, May CN, et al. Intrarenal blood flow distribution in hyperdynamic septic shock: effect of norepinephrine. Crit Care Med 2003; 31:2509-2513
20. Zhang H, Smail N, Cabral A, et al. Effects of norepinephrine on regional blood flow and oxygen extraction capabilities during endotoxic shock. Am J Respir Crit Care Med 1997; 155:537-544
21. Treggiari MM, Romand JA, Burgener D, et al. Effect of increasing norepinephrine dosage on regional blood flow in a porcine model of endotoxin shock. Crit Care Med 2002; 30:1334-1339
22. Boillot A, Massol J, Maupoil V, et al. Myocardial and vascular adrenergic alterations in a rat model of endotoxin shock: reversal by an anti-tumor necrosis factor-alpha monoclonal antibody. Crit Care Med 1997; 25:504-511
23. Martin C, Viviand X, Leone M, et al. Effect of norepinephrine on the outcome of septic shock. Crit Care Med 2000; 28:2758-2765
24. Morimatsu H, Uchino S, Chung J, et al. Norepinephrine for hypotensive vasodilatation after cardiac surgery: impact on renal function. Intensive Care Med 2003; 29:1106-1112
25. Bellomo R, Di Giantomasso D. Noradrenaline and the kidney: friends or foes? Crit Care 2001; 5:293-298